证券日报网讯 12月16日，和邦生物在互动平台回答投资者提问时表示，钢材、水泥等大宗原材料的价 格已大幅下降，根据目前的客观的市场条件，广安项目实际投资金额与公司原定的投资目标相比，有非 常大的节约空间。这样的市场条件，也正是公司实施大规模投资的机会。所以，公司当前整体工程进度 处于加速期，正大规模的开展项目工程招标和设备订购。至于最终能节约多少，涉及到这个项目是公司 的大型投资项目，为保证公平信息披露，公司会做一个新的预算，进行统一的信息披露。 （文章来源：证券日报） ...

每经AI快讯，有投资者在投资者互动平台提问：此前回购用于出售的股份现在是什么情况？是否完成 出售或者完成多少？盈亏如何？ （文章来源：每日经济新闻） 和邦生物（603077.SH）12月16日在投资者互动平台表示，目前，公司为维护公司价值及股东权益所回 购股份尚未出售，公司未来如有出售回购股份计划，会依法进行信息披露。 ...

从资金流向上来看，当日农化制品板块主力资金净流出8.6亿元，游资资金净流入1.48亿元，散户资金净 流入7.12亿元。农化制品板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 证券之星消息，12月9日农化制品板块较上一交易日下跌2.21%，和邦生物领跌。当日上证指数报收于 3909.52，下跌0.37%。深证成指报收于13277.36，下跌0.39%。农化制品板块个股涨跌见下表： ...

Group 1 - The glyphosate concept sector declined by 0.86%, ranking among the top declines in the concept sectors, with leading decliners including Runfeng Co., Xin'an Chemical, and Lier Chemical [1] - Among the concept stocks, four stocks experienced price increases, with Zhongnong United, Hongtaiyang, and Nuobixin rising by 1.40%, 0.34%, and 0.09% respectively [1] - The main capital outflow from the glyphosate concept sector was 42 million yuan, with nine stocks experiencing net outflows, led by Xingfa Group with a net outflow of 21.78 million yuan [1] Group 2 - The top three stocks with the largest capital outflows included Xin'an Chemical with a net outflow of 18.10 million yuan, Hebang Biotechnology with 12.91 million yuan, and Lier Chemical with 11.36 million yuan [1] - Stocks with the highest capital inflows included Runfeng Co. with 8.66 million yuan, Nuobixin with 7.98 million yuan, and Jiangshan Co. with 6.62 million yuan [2] - The trading volume for the top outflowing stock, Xingfa Group, was 1.95%, while the highest inflow stock, Runfeng Co., had a turnover rate of 0.47% [2]

Core Viewpoint - The company, Sichuan Hebang Biotechnology Co., Ltd., will hold an investor briefing on December 15, 2025, to discuss its Q3 2025 performance and financial results, allowing for interactive communication with investors [2][3]. Group 1: Meeting Details - The investor briefing is scheduled for December 15, 2025, from 15:00 to 16:00 [4]. - The meeting will take place at the Shanghai Stock Exchange Roadshow Center, accessible online [4]. - The format of the meeting will be an interactive online session [3][4]. Group 2: Participation Information - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date [5]. - Questions can be submitted by investors from December 8 to December 12, 2025, through the Roadshow Center's website or via the company's email [5]. - The company will address commonly asked questions during the briefing [5]. Group 3: Attendees - Key attendees from the company include the actual controller and director, Mr. He Zhenggang; the chairman and general manager, Mr. Zeng Xiaoping; the director and CFO, Mr. Wang Jun; the board secretary, Ms. Jiang Siying; and the independent director, Ms. Song Ying [4]. Group 4: Contact Information - For inquiries, investors can contact the company's board office at phone number 028-62050230 or via email at jsy@hebang.cn [6][7].

Core Viewpoint - Sichuan Hebang Biotechnology Co., Ltd. is holding a Q3 2025 performance briefing on December 15, 2025, to discuss its operational results and financial status with investors [2][3]. Group 1: Meeting Details - The meeting is scheduled for December 15, 2025, from 15:00 to 16:00 [6]. - It will take place at the Shanghai Stock Exchange Roadshow Center, accessible online [6]. - The format of the meeting will be an interactive online session [3][6]. Group 2: Participation Information - Investors can participate online via the Shanghai Stock Exchange Roadshow Center on the meeting date [5]. - Questions can be submitted from December 8 to December 12, 2025, through the Roadshow Center or via the company's email [5][4]. - The company will address commonly asked questions during the briefing [3][5]. Group 3: Attendees - Key attendees include the actual controller and director He Zhenggang, chairman and general manager Zeng Xiaoping, financial director Wang Jun, board secretary Jiang Siying, and independent director Song Ying [4].

自贡锂产业优势在于卤水提锂 近日，一则关于和邦生物（SH603077，股价2.36元，市值208.42亿元）的"小作文"在网络上传播，其中 提到，和邦生物可能投资了15亿元碳酸锂（氢氧化锂）项目。《每日经济新闻》记者核实发现，该项目 并非和邦生物投资，而是和邦生物控股股东的决策。 该项目的签约时间在12月1日，当日，和邦生物股价涨停。该项目地点在四川省自贡市富顺县，相较于 遂宁、德阳等布局较早的锂电区域，自贡的优势则是卤水提锂。 和邦生物未投资15亿元锂盐项目 上述"小作文"显示，和邦富顺碳酸锂（氢氧化锂）项目（通常表述为"碳酸锂/氢氧化锂项目"）总投资 额15亿元，地点在四川省自贡市富顺县。根据名称判断，投资方很可能涉及和邦生物。 和邦生物是一家以化工为主业的大型企业，近年来正积极向光伏玻璃、锂电材料等新能源领域战略转 型。其中还分析了和邦生物的战略选择——"对于和邦生物这样的传统化工巨头而言，进军锂电材料是 其寻求第二增长曲线、实现产业升级的关键一步"。不过，12月5日，和邦生物股价盘中未有异动。 记者核实发现，"自贡观察""富顺融媒"等平台确实在12月3日刊发了一篇文章——《投资15亿元！和邦 富顺碳酸 ...

| 证券代码：603077 | 证券简称：和邦生物 | 公告编号：2025-050 | | --- | --- | --- | | 债券代码：113691 | 债券简称：和邦转债 | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于 2025 年 12 月 08 日（星期一）至 12 月 12 日（星期五）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 jsy@hebang.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 四川和邦生物科技股份有限公司（以下简称"公司"）已于 2025 年 10 月 29 日发布《四川和邦生物科技股份有限公司 2025 年第三季度报告》，为便于广大投 资者更全面深入地了解公司 2025 年第三季度经营成果、财务状况，公司计划于 2025 年 12 月 15 日（星期一）15:00-16:00 举行 2025 年第三季度业绩说明会， 就投资者关心的问题进行交流。 一、说明会类型 本次投资者说明会以网络互动形式召开，公司将 ...

Core Viewpoint - The gold concept sector leads the market with a rise of 1.3%, indicating strong investor interest in gold-related stocks [1] Group 1: Sector Performance - The gold concept sector has increased by 1.3% [1] - Notable performers include: - Xiaocheng Technology, which surged by 12.94% [1] - Jiangxi Copper, which rose by 3.99% [1] - Nanjing Mining Group, which increased by 3.15% [1] - Shengtun Mining, Luoyang Molybdenum, and Hebang Biotechnology, all of which saw gains exceeding 2% [1]

Core Insights - The signing of the lithium carbonate (lithium hydroxide) project by Sichuan Hebang Group in Fushun County represents a significant investment of 1.5 billion yuan, marking a major achievement in attracting investment to the region [1][2] - The project aims to fill the gap in the positive electrode material industry, contributing to the development of a new chemical and renewable energy industry ecosystem in the region [1] - The establishment of the Fushun Chenguang Provincial Chemical Park, approved on October 23, will support the project and enhance the local industrial capacity [2] Investment and Economic Development - The project is seen as a strategic move to integrate into the Chengdu-Chongqing economic circle, enhancing Fushun's role in the new energy sector [1] - Sichuan Hebang Group plans to leverage its core advantages in resource integration and technology research and development to drive the project's success and contribute to local economic growth [2] - The local government, led by Fushun County officials, is committed to providing comprehensive support to ensure the project's timely commencement and operation [2] Industry Context - The lithium products produced will play an irreplaceable role in the production of positive electrode materials for power batteries, indicating a strong market potential [2] - The Fushun Chemical Park's 4.27 square kilometer area includes both developed and upcoming chemical zones, with plans for annual capacity expansion [2]